Companies
- Companies
- Company details
Peptor
Peptor based in Israel and Germany, is engaged in the discovery and development of novel therapies for the treatment of human autoimmune diseases and cancers.The company in detail
Summary
Peptor is a development stage company engaged in the discovery and development of immunotherapeutic drugs to treat autoimmune diseases and cancers.
R&D
To view this information, you must subscribe to Pharmalicensing Intelligence.
Partnerships
To view this information, you must subscribe to Pharmalicensing Intelligence.
Deals
To view this information, you must subscribe to Pharmalicensing Intelligence.
Senior management
To view this information, you must subscribe to Pharmalicensing Intelligence.
Board of directors
To view this information, you must subscribe to Pharmalicensing Intelligence.
Related Reports
Market Research Reports provided by reports.iptechex.com
Contact details
To view this information, you must subscribe to Pharmalicensing Intelligence.
Head office
Related companies
Related categories
- Industry sector
- Biotechnology / Human therapeutics
- Biotechnology / Human diagnostics
- Drug discovery / Combinatorial biology
- Drug discovery / Combinatorial chemistry
- Drug discovery / High throughput screening
- Drug discovery / Proteomics
- Pharmaceutical / Prescription
- Therapeutic target
- Genito-urinary / Urinary / Diuretic
- Genito-urinary / Urinary / Urinary tract disorder (other)
- Immune related disorders / Immunostimulation
- Immune related disorders / Immunosuppression
- Metabolism / Diabetes type I
- Musculoskeletal / Musculoskeletal disorder (other)
- Musculoskeletal / Skeletal / Rheumatoid arthritis
- Oncology / Treatments / Chemotherapy
© Copyright 1998-2013 IP Technology Exchange, Inc All rights reserved. Terms and Conditions | Contact us